Bioweapons Research Proliferates

Photos courtesy of Engineering Animation, Inc. BIOLOGICAL DEFENSE: Among the tools to counter effects from biological weapons, bioengineered red blood cells (above) can patrol the circulatory system, sponging up viral particles and carrying them to the liver for destruction. Synthetic macromolecules, or dendrimers (right), can capture viral particles and prevent further viral destruction of healthy cells. Biological weapons have been around since medieval warriors hurled plague-ridden corp

Written byRicki Lewis
| 10 min read

Register for free to listen to this article
Listen with Speechify
0:00
10:00
Share

In October 1997, a United Nations special commission discovered evidence of bioweapons in Iraq; a month later, Iraq barred a U.S. team from inspecting suspect facilities, nearly precipitating war. On the bioterrorist front, in February 1998 two men were arrested in Las Vegas, Nev., for allegedly transporting anthrax bacilli for the purpose of creating a weapon. Authorities dropped the charges within days, however, when the FBI determined that the men had a vaccine strain, which they reportedly were stockpiling in case of attack by Iraq. And between the Iraq and Las Vegas incidents, President Bill Clinton announced last January in his State of the Union address his intent to strengthen the 1972 Biological Weapons Convention (BWC) "with a new international inspection system to detect and deter cheating."

On the domestic front, more than 100 U.S. cities began biowarfare preparedness programs in the summer of 1997 as part of the federal ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies